CANCER IMMUNOTHERAPY CONSORTIUM Trademark

Trademark Overview


On Wednesday, March 10, 2010, a trademark application was filed for CANCER IMMUNOTHERAPY CONSORTIUM with the United States Patent and Trademark Office. The USPTO has given the CANCER IMMUNOTHERAPY CONSORTIUM trademark a serial number of 77955278. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 20, 2017. This trademark is owned by The Cancer Research Institute. The CANCER IMMUNOTHERAPY CONSORTIUM trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Organizing and conducting conferences regarding cancer vaccine research and development

Medical research services in the field of cancer vaccine research and development
cancer immunotherapy consortium

General Information


Serial Number77955278
Word MarkCANCER IMMUNOTHERAPY CONSORTIUM
Filing DateWednesday, March 10, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 20, 2017
Registration Number3932975
Registration DateTuesday, March 15, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"CONSORTIUM"
Goods and ServicesOrganizing and conducting conferences regarding cancer vaccine research and development
Goods and ServicesMedical research services in the field of cancer vaccine research and development

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 20, 2017
Primary Code041
First Use Anywhere DateThursday, March 18, 2010
First Use In Commerce DateThursday, March 18, 2010

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 20, 2017
Primary Code042
First Use Anywhere DateThursday, March 18, 2010
First Use In Commerce DateThursday, March 18, 2010

Trademark Owner History


Party NameThe Cancer Research Institute
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNew York, NY 10006

Party NameThe Cancer Research Institute
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10006

Trademark Events


Event DateEvent Description
Friday, October 20, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, March 15, 2011REGISTERED-SUPPLEMENTAL REGISTER
Thursday, February 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 10, 2011ASSIGNED TO LIE
Thursday, January 13, 2011NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, January 12, 2011APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, January 12, 2011USE AMENDMENT ACCEPTED
Wednesday, January 5, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, January 5, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 5, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, January 5, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, December 17, 2010AMENDMENT TO USE PROCESSING COMPLETE
Friday, December 17, 2010USE AMENDMENT FILED
Thursday, December 16, 2010TEAS AMENDMENT OF USE RECEIVED
Thursday, December 16, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 16, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 16, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 17, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 17, 2010NON-FINAL ACTION E-MAILED
Thursday, June 17, 2010NON-FINAL ACTION WRITTEN
Monday, June 14, 2010ASSIGNED TO EXAMINER
Monday, March 15, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 13, 2010NEW APPLICATION ENTERED IN TRAM